Prognostic factors for disease-free survival on univariate analysis (log-rank test) in nonmetastatic patients
n = 75 | Patients | % | χ2 | P |
---|---|---|---|---|
Estrogen receptor negative versus estrogen receptor positive | 31 | 41 | 8.13 | 0.004 |
Cytokeratin-positive cells in bone marrow | 37 | 49 | 6.24 | 0.012 |
Clinical N1N2 versus N0 | 39 | 52 | 5.79 | 0.016 |
Clinical T4 versus T3/T2/T1 | 16 | 21 | 4.75 | 0.029 |
Tumor emboli | 33 | 44 | 3.90 | 0.048 |
Cytokeratin-positive cells in peripheral blood | 12 | 16 | 1.99 | 0.157 |
Tumor grade II/III versus I | 61 | 81 | 1.44 | 0.230 |
Pre- versus postmenopausal | 43 | 57 | 0.92 | 0.337 |
Progesterone receptor negative versus progesterone receptor positive | 45 | 76 | 0.88 | 0.347 |
Histological pN > 3N+ | 33 | 44 | 0.85 | 0.354 |
Ductal versus other histology | 65 | 87 | 0.01 | 0.957 |